Subjects and setting
Patients treated with TL from January 2020 to December 2020 were prospectively recruited from our medical center. Patients benefited from tracheoesophageal puncture and 1-month post-TL VP. The surgeon used the Provox® 2 type prosthesis (Atos Medical AB, Hörby, Sweden). Patients were followed by an experienced otolaryngologist and SLP for the voice rehabilitation and the oncological follow-up. The first VP change was performed by the senior SLP (GD) who was supervised by the senior head and neck surgeon (SH). The rest of the VP changes were performed by the same SLP without surgeon supervision; the surgeon being however called in case of problems.